Page breadcrumb nav

VAERS Report 2157308

Case Report Section

Vaer Report Details

Age: 60 years old

Gender: Female

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (PFIZER-BIONTECH))

Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: fe2707


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2021-07-12
Date of Onset
0
Number of days (onset date – vaccination date)
0
Adverse Event Description

burning eyes; oculomotor spasm; hairy skin itching; migraine; facial paraesthesia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: it-minisal02-842718. a 60 year-old female patient (unknown if pregnant) received bnt162b2 (comirnaty), intramuscular, administered in arm left, administration date 12jul2021 (lot number: fe2707) at the age of 60 years as dose 1, single for covid-19 immunisation. relevant medical history included: "primary hyperparathyroidism" (unspecified if ongoing); "migraine" (unspecified if ongoing); "pulmonary nodule under investigation" (unspecified if ongoing), notes: under investigation. the patient's concomitant medications were not reported. the following information was reported: eye irritation (medically significant) with onset 12jul2021, outcome "not recovered", described as "burning eyes"; oculogyric crisis (medically significant) with onset 12jul2021, outcome "not recovered", described as "oculomotor spasm"; pruritus (medically significant) with onset 12jul2021, outcome "not recovered", described as "hairy skin itching"; migraine (medically significant) with onset 12jul2021, outcome "not recovered", described as "migraine"; paraesthesia (medically significant) with onset 12jul2021, outcome "not recovered", described as "facial paraesthesia". the patient underwent the following laboratory tests and procedures: quality of life decreased: (2021) 8/10; specialist consultation: (2021) unknown results. on 14feb2022: the seriousness of the suspected adverse reaction is updated from "serious or permanent invalidity" to "serious-other clinically relevant condition". reporter comment: primary hyperparathyroidism - migraine - pulmonary nodule under investigation - no follow-up attempts are possible. no further information is expected

Lab Data
test date: 2021; test name: impact on quality of life; result unstructured data: test result:8/10; test date: 2021; test name: visit to oculist; result unstructured data: test result:unknown results
List of symptoms
paraesthesia pruritus migraine eye irritation quality of life decreased specialist consultation oculogyric crisis
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na